BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 2209315)

  • 1. Effects of fish oil supplements in NIDDM subjects. Controlled study.
    Hendra TJ; Britton ME; Roper DR; Wagaine-Twabwe D; Jeremy JY; Dandona P; Haines AP; Yudkin JS
    Diabetes Care; 1990 Aug; 13(8):821-9. PubMed ID: 2209315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of fish oil supplementation on glucose and lipid metabolism in NIDDM.
    Borkman M; Chisholm DJ; Furler SM; Storlien LH; Kraegen EW; Simons LA; Chesterman CN
    Diabetes; 1989 Oct; 38(10):1314-9. PubMed ID: 2676659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effects of fish oil on insulin resistance and plasma lipoproteins in NIDDM patients with hypertriglyceridemia.
    Rivellese AA; Maffettone A; Iovine C; Di Marino L; Annuzzi G; Mancini M; Riccardi G
    Diabetes Care; 1996 Nov; 19(11):1207-13. PubMed ID: 8908381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of n-3 fatty acids from fish oil on hemostasis, blood pressure, and lipid profile of dialysis patients.
    Donnelly SM; Ali MA; Churchill DN
    J Am Soc Nephrol; 1992 May; 2(11):1634-9. PubMed ID: 1610984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a small quantity of omega-3 fatty acids on cardiovascular risk factors in NIDDM. A randomized, prospective, double-blind, controlled study.
    Axelrod L; Camuso J; Williams E; Kleinman K; Briones E; Schoenfeld D
    Diabetes Care; 1994 Jan; 17(1):37-44. PubMed ID: 8112187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma lipid levels and platelet and neutrophil function in patients with vascular disease following fish oil and olive oil supplementation.
    Mori TA; Vandongen R; Mahanian F; Douglas A
    Metabolism; 1992 Oct; 41(10):1059-67. PubMed ID: 1328817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supplementation with n-3 fatty acids reduces triglycerides but increases PAI-1 in non-insulin-dependent diabetes mellitus.
    Boberg M; Pollare T; Siegbahn A; Vessby B
    Eur J Clin Invest; 1992 Oct; 22(10):645-50. PubMed ID: 1459169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A controlled study on the effects of n-3 fatty acids on lipid and glucose metabolism in non-insulin-dependent diabetic patients.
    Annuzzi G; Rivellese A; Capaldo B; Di Marino L; Iovine C; Marotta G; Riccardi G
    Atherosclerosis; 1991 Mar; 87(1):65-73. PubMed ID: 1872925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the effects of dietary n-3 fatty acids (Maxepa) on plasma lipids and lipoproteins in patients with hyperlipidaemia.
    Simons LA; Hickie JB; Balasubramaniam S
    Atherosclerosis; 1985 Jan; 54(1):75-88. PubMed ID: 3888229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a fish oil supplement on platelet function, haemostatic variables and albuminuria in insulin-dependent diabetics.
    Haines AP; Sanders TA; Imeson JD; Mahler RF; Martin J; Mistry M; Vickers M; Wallace PG
    Thromb Res; 1986 Sep; 43(6):643-55. PubMed ID: 3020732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of n-3 fatty acid administration on selected indicators of cardiovascular disease risk in patients with type 2 diabetes mellitus].
    Habán P; Simoncic R; Klvanová I; Ozdín L; Zideková E
    Bratisl Lek Listy; 1998 Jan; 99(1):37-42. PubMed ID: 9588078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Maxepa on serum lipids in hypercholesterolaemic subjects.
    Dart AM; Riemersma RA; Oliver MF
    Atherosclerosis; 1989 Dec; 80(2):119-24. PubMed ID: 2692571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supplementation with long-chain n-3 fatty acids in non-insulin-dependent diabetes mellitus (NIDDM) patients leads to the lowering of oleic acid content in serum phospholipids.
    Haban P; Zidekova E; Klvanova J
    Eur J Nutr; 2000 Oct; 39(5):201-6. PubMed ID: 11131366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of diets supplemented with fish oil or olive oil on plasma lipoproteins in insulin-dependent diabetics.
    Mori TA; Vandongen R; Masarei JR; Rouse IL; Dunbar D
    Metabolism; 1991 Mar; 40(3):241-6. PubMed ID: 2000036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of dietary fish oil on platelet function and plasma lipids in hyperlipoproteinemic and normal subjects.
    Zucker ML; Bilyeu DS; Helmkamp GM; Harris WS; Dujovne CA
    Atherosclerosis; 1988 Sep; 73(1):13-22. PubMed ID: 3178928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of a dietary supplement of n-3 polyunsaturated fat on platelet lipid composition, platelet function and platelet plasma membrane fluidity in healthy volunteers.
    Gibney MJ; Bolton-Smith C
    Br J Nutr; 1988 Jul; 60(1):5-12. PubMed ID: 3408705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind, placebo-controlled trial of fish oil concentrate (MaxEpa) in stroke patients.
    Green D; Barreres L; Borensztajn J; Kaplan P; Reddy MN; Rovner R; Simon H
    Stroke; 1985; 16(4):706-9. PubMed ID: 3895595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of dietary marine oils and olive oil on fatty acid composition, platelet membrane fluidity, platelet responses, and serum lipids in healthy humans.
    Vognild E; Elvevoll EO; Brox J; Olsen RL; Barstad H; Aursand M; Osterud B
    Lipids; 1998 Apr; 33(4):427-36. PubMed ID: 9590631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a fish oil supplement on blood pressure and serum lipids in patients treated for coronary artery disease.
    Bairati I; Roy L; Meyer F
    Can J Cardiol; 1992; 8(1):41-6. PubMed ID: 1617510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary fish oil enhances insulin sensitivity in miniature pigs.
    Behme MT
    J Nutr; 1996 Jun; 126(6):1549-53. PubMed ID: 8648427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.